ArticleFrontiers in immunology2025

Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis.

Erika Biegelmeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.